Showing results (121-130 of 190) with videos related to
Sort By:
Pageof 19
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.Clinical Breast Cancer|February 14, 2008
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanesJoanne L Blum, Michael A Savin, Gerald Edelman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patientsJ A O'Shaughnessy, A M Denicoff, D J Venzon, et al.Instructional Course Lectures|November 25, 2025
Evidence-Based Management of Common Hand and Wrist Injuries: Tips, Pearls, and ControversiesMichael B Gottschalk, Eric R Wagner, Michelle G Carlson, et al.American Journal of Surgery|March 10, 2004
Current comprehensive assessment and management of women at increased risk for breast cancerAlan B Hollingsworth, S Eva Singletary, Monica Morrow, et al.Clinical Breast Cancer|July 9, 2005
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancerJoyce A O'Shaughnessy, Romnee S Clark, Joanne L Blum, et al.Clinical Breast Cancer|March 20, 2010
A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapyJohn Pippen, Anthony D Elias, Marcus Neubauer, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2024
Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry StudyTara B Sanft, Jenna Wong, Brandon O'Neal, et al.Stem Cells (Dayton, Ohio)|January 1, 1996
Early suppressive effects of chemotherapy on recovery of bone marrow megakaryocyte precursors: possible relationship to platelet recoveryM K Warren, J Zujewski, W L Rose, et al.Breast Cancer Research : BCR|July 9, 2016
"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapyChristopher Twelves, Javier Cortes, Peter A Kaufman, et al.Pageof 19